Matches in Nanopublications for { ?s ?p "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP387445.RAY_-GlbC99y2ZMItS-PPRnIvfKFO4uNL2i7PX7gvp4jg130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387445.RAY_-GlbC99y2ZMItS-PPRnIvfKFO4uNL2i7PX7gvp4jg130_provenance.
- assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP622094.RAZFQa5K3vmbUJgPnMaStRfngEkRHmnIL7tUemnRdlXA8130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622094.RAZFQa5K3vmbUJgPnMaStRfngEkRHmnIL7tUemnRdlXA8130_provenance.
- NP260163.RAdytq5nvnpt9Iah6Bw9ddEB8My_P2Z2D9cLxuQIGQteA130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260163.RAdytq5nvnpt9Iah6Bw9ddEB8My_P2Z2D9cLxuQIGQteA130_provenance.
- NP261309.RAaAoIDBuP3eiOkpWMXlT3ljJyihT70l4xjtVJFxeAPBU130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261309.RAaAoIDBuP3eiOkpWMXlT3ljJyihT70l4xjtVJFxeAPBU130_provenance.
- assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP878615.RAmoni8lIn09Q3joOsAJWv5eFjCnBeAYZP3RFOBT6DWbk130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878615.RAmoni8lIn09Q3joOsAJWv5eFjCnBeAYZP3RFOBT6DWbk130_provenance.
- NP1004624.RAnP_i-dKsKeob8wouy0FITxU3ZGqSgztmsyxPXD6ruyo130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004624.RAnP_i-dKsKeob8wouy0FITxU3ZGqSgztmsyxPXD6ruyo130_provenance.
- NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004622.RAJubVNwLwjKkZ-eASaYol1QrKa4NiFC6VwsVmeGUFab0130_provenance.
- NP1004625.RA8qL4z6wbjtWrhAYm6wkSGHRlyfmzzcUbLCco9T7WaV0130_assertion description "[In conclusion, we demonstrated that SCC-S2 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin D1 and phospho-Rb modulation, which makes SCC-S2 a candidate therapeutic target in colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004625.RA8qL4z6wbjtWrhAYm6wkSGHRlyfmzzcUbLCco9T7WaV0130_provenance.